Dr Danny Meyersfeld completed his PhD in Molecular Biology in 2005 at the University of Witwatersrand, South Africa. Following two years of post-doctoral research, and passionate about the concept of personalised medicine, Danny set up DNAlysis Biotechnology, a company dedicated to the widespread adoption of genomic insights into clinical practice.
Danny is passionate about making available to doctors in sub-Saharan Africa the same tools that are available elsewhere in the world and is determined to ensure the appropriate and responsible integration of genetic tests into clinical practice.
To this end, the DNAlysis portfolio of genetic tests has been developed with a focus on scientific integrity and accuracy, and a significant portion of time is spent on the upskilling of medical practitioners to try to ease the transition of complex genetics into medicalpractices.
